PAX9 (Paired box gene 9)

2005-08-01   Ewan Robson , Jess Whall , Michael Eccles 

Developmental Genetics Group, Department of Pathology, University of Otago, PO Box 913,Dunedin 9015, New Zealand

Identity

HGNC
LOCATION
14q13.3
LOCUSID
ALIAS
STHAG3
FUSION GENES

DNA/RNA

Description

4 exons

Transcription

3 alternative splicing isoforms

Pseudogene

No

Proteins

Description

341 amino acids; 36.3 kDa

Expression

PAX9 is expressed in developing somites, specifically in the posterior ventrolateral region. These cells undergo an epithelial-mesenchymal transition, gaining increased motile capability as a consequence. Subsequent migration of this population generates the lateral sclerotome, which in turn gives rise to the ribs and neural arches. PAX9 contains a DNA binding paired domain, an octapeptide region and a carboxyl-terminal transactivation domain.

Localisation

Nuclear.

Function

PAX9 is a transcription factor that regulates the expression of genes involved in mediating cell proliferation, resistance to apoptosis, and cell migration. Mice homozygous for Pax9 mutations die shortly after birth, lacking the thymus, parathyroid glands and ultimobranchial bodies derived from the third and fourth pharangeal pouches, presenting aberrant head and visceral skeleton development and a complete absence of teeth.

Homology

PAX9 shares homology through the conserved paired box domain with the other members of the nine strong PAX gene family.

Mutations

Germinal

PAX9 mutations are associated with oligodontia.

Implicated in

Entity name
Oligodontia
Disease
Caused by missense and frameshift PAX9 mutations. Patients present normal primary dentition but lack most permanent molars.
Entity name
Jarcho-Levin syndrome
Disease
In humans, a reduction in expression levels of Pax9, together with those of the related Pax1 gene, have been reported in vertebral column chondrocytes of autopsied foeti presenting Jarcho-Levin syndrome, a segmentation anomaly affecting thoracic and vertebral skeletal development. This syndrome shares similarities with the phenotype of the Pax9/Pax1 double mutant mouse.
Entity name
Oesophageal invasive carcinoma and epithelial dysplasia.
Disease
PAX9 expression levels are significantly reduced in oesophageal invasive carcinoma and epithelial dysplasias compared to levels in normal tissue. There is a correlation between decreasing PAX9 expression and increased malignancy of the cancer.
Prognosis
Elevated PAX9 expression may be a useful prognostic marker indicative of favourable outcome in patients presenting oesophageal invasive carcinoma.

Bibliography

Pubmed IDLast YearTitleAuthors
128334072003Aberrant Pax1 and Pax9 expression in Jarcho-Levin syndrome: report of two Caucasian siblings and literature review.Bannykh SI et al
92979661997Pax genes and organogenesis.Dahl E et al
119414882002Haploinsufficiency of PAX9 is associated with autosomal dominant hypodontia.Das P et al
121158742002Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus.Gerber JK et al
156158742005Novel mutation of the initiation codon of PAX9 causes oligodontia.Klein ML et al
145712722003A missense mutation in PAX9 in a family with distinct phenotype of oligodontia.Lammi L et al
97322711998Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities.Peters H et al
105560641999Pax1 and Pax9 synergistically regulate vertebral column development.Peters H et al
124905542003Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome.Rodrigo I et al
106151202000Mutation of PAX9 is associated with oligodontia.Stockton DW et al
16726611991The paired box encodes a second DNA-binding domain in the paired homeo domain protein.Treisman J et al

Other Information

Locus ID:

NCBI: 5083
MIM: 167416
HGNC: 8623
Ensembl: ENSG00000198807

Variants:

dbSNP: 5083
ClinVar: 5083
TCGA: ENSG00000198807
COSMIC: PAX9

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000198807ENST00000361487P55771
ENSG00000198807ENST00000361487Q2L4T1
ENSG00000198807ENST00000402703P55771
ENSG00000198807ENST00000402703Q2L4T1

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
185198262008Molecular genetics of successful smoking cessation: convergent genome-wide association study results.130
126576352003Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.33
216266772011Isolated oligodontia associated with mutations in EDARADD, AXIN2, MSX1, and PAX9 genes.33
124908782002Concomitant occurrence of canine malposition and tooth agenesis: evidence of orofacial genetic fields.25
119414882002Haploinsufficiency of PAX9 is associated with autosomal dominant hypodontia.24
192792072009Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.24
189786782008Candidate gene/loci studies in cleft lip/palate and dental anomalies finds novel susceptibility genes for clefts.21
194532612009High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.20
156158742005Novel mutation of the initiation codon of PAX9 causes oligodontia.19
206348912010Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.18

Citation

Ewan Robson ; Jess Whall ; Michael Eccles

PAX9 (Paired box gene 9)

Atlas Genet Cytogenet Oncol Haematol. 2005-08-01

Online version: http://atlasgeneticsoncology.org/gene/41644/pax9